An Analysis of “No Effect of Insulin Pen with Memory Function on Glycemic Control in a Patient Cohort with Poorly Controlled Type 1 Diabetes: A Randomized Open-Label Study”

Por Ampudia-Blasco, Francisco Javier
Publicado em 2012

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

Por Ampudia-Blasco, Francisco Javier, Romera, Irene, Ariño, Bernat, Gomis, Ramón
Publicado no Int J Gen Med (2017)

Stability and Performance of Rapid-Acting Insulin Analogs Used for Continuous Subcutaneous Insulin Infusion: A Systematic Review

Por Kerr, David, Wizemann, Erik, Senstius, Jakob, Zacho, Mette, Ampudia-Blasco, Francisco Javier
Publicado em 2013

Reimbursement for Continuous Glucose Monitoring: A European View

Por Heinemann, Lutz, Franc, Sylvia, Phillip, Moshe, Battelino, Tadej, Ampudia-Blasco, Francisco Javier, Bolinder, Jan, Diem, Peter, Pickup, John, Hans DeVries, J.
Publicado em 2012